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Abstract
Background: Several observational studies suggest that coffee consumption may be associated with an increased
risk of gastric cancer, but the results are inconsistent. We conducted a meta-analysis to evaluate the relationship of
coffee consumption with gastric cancer risk and quantify the dose–response relationship between them.
Methods: Relevant prospective studies were identified by a search of PubMed, Embase, and Web of Science to
May 2015 and by reviewing the references of retrieved articles. Two independent reviewers extracted data and
performed the quality assessment. A random-effects model was used to calculate the pooled risk estimates and
95 % confidence intervals (CI). The heterogeneity was assessed using the I2 statistic. Publication bias was assessed
by using funnel plot, the Begg test and the Egger test.
Results: Thirteen prospective cohort studies with 20 independent reports involving 3,368 patients with gastric cancer
and 1,372,811 participants during a follow-up period ranging from 4.3–8 years were included. Compared with the
lowest consumption level of coffee, the pooled relative risk (RR) was 1.13 (95 % CI: 0.94–1.35). The dose–response
analysis indicated that, the RR of gastric cancer was 1.03 (95 % CI; 0.95–1.11) for per 3 cups/day of coffee consumption.
Any nonlinear association of gastric cancer risk with coffee consumption was not found (P for nonlinearity = 0.68).
Subgroup analyses indicated that the pooled RR for participants from the United States comparing the highest with
the lowest coffee consumption was 1.36 (95 % CI, 1.06–1.75, I2 = 0 %). In addition, people with higher coffee
consumption was associated with 25 % higher risk of gastric cancer in equal to or less than 10 years follow-up group
(RR = 1.25; 95 % CI, 1.01–1.55, I2 = 0 %). Visual inspection of a funnel plot and the Begg’s and the Egger’s tests did not
indicate evidence of publication bias.
Conclusions: This meta-analysis does not support the hypothesis that coffee consumption is associated with the risk
of gastric cancer. The increased risk of gastric cancer for participants from the United States and equal to or less than
10 years follow-up group associated with coffee consumption warrant further studies.
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Background
Gastric cancer is the fourth most common cancer, be-
hind lung, breast and colorectal cancers, and the second
most common cause of cancer death in the world [1, 2].
It is estimated that 951,600 new stomach cancer cases
and 723,100 deaths occurred in 2012. Gastric cancer
rates are generally about twice as high in men as in
women and vary widely among countries. Generally, the
incidence of gastric cancer is highest in Eastern Asia
(particularly in Korea, Mongolia, Japan, and China) [1].
Regional variations maybe reflect the differences in food
storage, the availability of fresh produce and the preva-
lence of Helicobacter pylori infection [3]. Therefore, the
identification of modifiable risk factors for the preven-
tion of gastric cancer is of considerable public health im-
portance. Besides Helicobacter pylori infection, smoking
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and alcohol intake, dietary factors are suggested to be
associated with the development of gastric cancer [4–7].
Coffee is one of the most widely consumed beverages
worldwide, with a yearly world average consumption of
1.1 kg per capita, which reaches 4.5 kg in industrialized
countries [8]. Thus, any health effect of coffee is an im-
portant issue of public health [9]. More and more people
and investigations focused on the association between
coffee consumption and gastric cancer risk. The possible
relation between coffee consumption and gastric cancer
has been of considerable interest since the early 1960s,
when a case–control study reported by Higginson sug-
gested that the coffee might be a risk factor for gastric
cancer [10]. Since then, a number of epidemiological
studies have assessed the association between coffee
consumption and gastric cancer risk, with the inconsist-
ent results. A meta-analysis [11] in 2006 reported a null
association between coffee consumption and gastric
cancer risk, which took pooled effect size from 16 case–
control studies and 7 cohort studies. Although the re-
view included 7 cohort studies, the sample size was only
166,538, which lacked more powerful evidence. It is well
known that prospective cohort study owned the stron-
gest evidence in the observational studies. Prospective
data to exclude some possible sources of bias that may
exist in retrospective data could do good to come to
more definitive conclusions [12]. The review did not
fully explore the potential publication bias. Furthermore,
the World Cancer Research Fund report of 2007 con-
cluded that the evidence for an association between the
consumption of coffee and the risk of gastric cancer was
limited and inconsistent [13]. Since the publication of
the last review on this topic, many more prospective
studies have emerged, which could further contribute to
the pooled data and allow further investigation into any
association between coffee consumption and gastric
cancer. Given that coffee is consumed very commonly
and the morbidity and mortality of gastric cancer are
high worldwide, clarifying this issue is of important pub-
lic health and etiology implication. Thus, we performed
an updated meta-analysis of prospective cohort studies
to investigate the association between coffee consump-
tion and the risk of gastric cancer and quantify the




This meta-analysis was conducted according to the
checklist of the Meta-analysis of Observational Studies
in Epidemiology (MOOSE) guidelines [14]. We compre-
hensively searched PubMed, Embase, and Web of Science
databases from their inception through May 2015 for
prospective cohort studies published in peer-reviewed
journals describing an association between coffee con-
sumption and risk of gastric cancer. We used “coffee”
OR “caffeine” OR “decaffeinated” OR “dietary intake”
OR “beverages” and “stomach” OR “gastric” combined
with “cancer” OR “carcinoma” OR “tumor” “neoplasm”
and “cohort studies” OR “prospective studies” OR “follow-
up studies” as the search terms. The search was restricted
to human studies. No restrictions were imposed on lan-
guage. In addition, references of the retrieved articles were
reviewed to identify additional studies. We did not contact
authors of the primary studies for additional information.
Inclusion criteria and exclusion criteria
Studies meeting the following criteria were included in
the meta-analysis: (1) the study was a prospective cohort
study design; (2) frequency and amount of coffee con-
sumption were provided; (3) the exposures of interest
were total coffee, caffeinated coffee, or decaffeinated cof-
fee consumption; (4) the outcome of interest was gastric
cancer; (5) the participants were free of gastric cancer at
study entry; (6) the study provided the relative risk (RR)
and the corresponding 95 % confidence interval (CI) for
the association between coffee consumption and gastric
cancer or sufficient data to calculate them.
Studies were excluded if: (1) the study was case–control
or cross-sectional design; (2) the exposure was mixed
beverage, in which the effect of coffee could not be
separated; (3) only surrogate nutrients of coffee were
reported; and (4) no categories of coffee intake were
reported that could not allow for adequate classifica-
tion of intake. If multiple published reports were
from the same study cohort, only the most recent or
informative one was included. Two reviewers (L.Q.L
and Y.G) independently reviewed all studies by title
or abstract or full text. Disagreements were resolved
through consultation with the third reviewer (Z.X.L).
Data extraction
We extracted the following information from studies
included: name of the first author, year of publication,
study location, characteristics of study population at
baseline, duration of follow-up, method of exposure
assessment, outcome measurements, number of cases,
number of participants, RR or hazard ratio (HR) and
corresponding 95 % CI for all categories of coffee con-
sumption, and covariates adjusted in the multivariable
analysis. We extracted risk estimates with the most
adjustment (when available). For dose–response analysis,
when studies reported the consumption in milliliters per
day or week or month, we standardized all data into
cups per day, using standard units of 125 ml for coffee
consumption [15]. Data extraction was conducted inde-
pendently by two authors (L.Q.L and Y.G). Interobserver
agreement was assessed using Cohen kappa (κ) and any
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disagreements were resolved by discussion with the third
author (Z.X.L.).
Quality assessment
Two reviewers (L.Q.L and Y.G) independently performed
the quality assessment by using the Newcastle-Ottawa
Scale [16], which is a nine-point scale that allocated points
based on the selection process of cohorts (0-4points), the
comparability of cohorts (0–2 points), and the assessment
of outcomes of study participants (0-3points). We
assigned scores of 0–3, 4–6, and 7–9 for low, moderate,
and high quality of studies, respectively.
Statistical analyses
We preferentially pooled multivariable adjusted risk esti-
mates where such estimates were reported. If adjusted
analysis was unavailable (n = 3 studies), we pooled the
unadjusted estimate. The RRs were considered as the
common measurement of the association between coffee
consumption and gastric cancer, and the HRs were con-
sidered equivalent to RRs. As different studies might re-
port different exposure categories (dichotomous, thirds,
quarters, or fifths), we used the study specific RR for the
highest versus the lowest category of coffee consumption
exposure for the meta-analysis. We pooled the RRs for
the highest versus the lowest exposure categories of cof-
fee consumption from each study using random-effects
models, which consider both within- and between-study
variation [17]. Any studies stratified by sex or type of
gastric cancer were considered as independent reports.
We performed the dose–response meta-analysis based
on the method described by Greenland and Longnecker
[18] and Orsini et al. [19]. The amount of coffee con-
sumption, the distributions of cases and person years,
and RRs and 95 % CI were extracted according to the
method. If the person years were not available for each
category of coffee consumption, but reported the total
number of cases/person-years, we estimated the distri-
bution. If consumption of coffee was analyzed by quar-
tiles (and could be approximated), e.g., the total number
of person years was divided by 4 when the data were
analyzed by quartiles in order to derive the number of
person-years in each quartile [20].
The median or mean coffee consumption in each
category was assigned to the corresponding dose of con-
sumption. The midpoint of the upper and lower bound-
aries was considered the dose of each category if the
median or the mean intake per category was not avail-
able. If the highest category was open-ended, the mid-
point of the category was set at 1.5 times the lower
boundary. When the lower boundary for the lowest
category was not provided, the assigned median value
was half of the upper boundary of that category.
To evaluate a potential non-linear dose–response rela-
tionship between coffee consumption and the risk of gastric
cancer, we used a restricted cubic spline regression model
with three knots at percentiles 10 %, 50 %, and 90 % of the
distribution [21]. A P value for nonlinearity was calculated
by testing against the null hypothesis that the coefficient of
the second spline transformation was equal to zero [22].
Statistical heterogeneity among studies was evaluated
using the I2 statistic, where values of 25 %, 50 % and
75 % represent cut-off points for low, moderate and high
degrees of heterogeneity, respectively [23]. Subgroup
analyses for sex, ethnicity, age, smoking, alcohol intake,
and body mass index (BMI) were conducted to explore
potential sources of study heterogeneity and examine the
robustness of the primary results. In sensitive analyses, we
conducted a leave-one-out analysis [24] for each study to
examine the magnitude of influence of each study on
pooled RRs. Potential publication bias was evaluated
through funnel plot and with the Begg’s and the Egger’s
tests [25, 26]. All analyses were performed with STATA
statistical software (version 12.0; College Station, TX, USA).
All tests were two sided with a significance level of 0.05.
Results
Literature search and study evaluation
The process of study identification and inclusion was
shown in Fig. 1. Initially we retrieved 217 articles from
the PubMed, 186 articles from the Embase, and 146 arti-
cles from the Web of Science. Of which 173 articles
were identified as potentially relevant. After assessing
the titles and abstracts, 157 studies were excluded be-
cause of non-compliance with the inclusion criteria.
After retrieving the full text review of the remaining 16
articles for detailed evaluation, 3 articles were excluded
because they did not report RRs and the corresponding
95 % CI of interest or provide sufficient data to calculate
them. Finally, 13 prospective cohort studies [27–39]
were included in the meta-analysis. Interobserver agree-
ment (κ) between reviewers for study inclusion was very
high (κ = 0.98). The average score for the quality assess-
ment of included studies was 7.8, and the score for all
studies was 6 or above (moderate or high quality). Not-
ably, in dose–response analysis, 2 studies [31, 33] were
excluded because of less than three categories of coffee
consumption, and 2 studies [32, 36] were excluded be-
cause either the number of case or person years of each
coffee consumption category was not available. Finally, 9
studies [27–30, 34, 35, 37–39] were included in the
dose–response analysis of coffee consumption with the
risk of gastric cancer.
Study characteristics
The characteristics of 13 prospective cohort studies in-
cluded are summarized in Table 1. These studies were
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published between 1986 and 2015. The size of the
cohorts ranged from 3,158–481,563, with a total
1,372,811and the follow-up duration ranged from 4.3–
18 years. The number of gastric cancer cases diagnosed
in the primary studies ranged from 51–683, with a total
of 3,368. Three studies were conducted in the United
States [28, 30, 36], two in Norway [27, 29], two in Japan
[32, 33], two in Sweden [34, 35], one in Netherlands
[31], one in Finland [37], and one in Singapore [38].
(The study of Sanikini et al. [39] was a multi-country
study conducted in Europe). Four studies [27, 32, 35, 36]
reported results for both men and women, six studies
[29, 30, 33, 37–39] reported the results by sex separately,
one study [34] reported results for women only, and two
studies [28, 31] reported results for men only. One study
[36] reported results by anatomical site. Six studies
[27, 28, 30, 31, 33, 37] assessed coffee consumption
without using a specific dietary assessment method, and
the rest of the studies assessed coffee consumption by
food frequency questionnaires (FFQ) or diet records.
Coffee consumption and the risk of gastric cancer
Figure 2 showed the results from the random-effects
meta-analysis combining the RRs for gastric cancer in
Fig. 1 Flow chart showing the relevant studies of coffee consumption in relation to gastric cancer
Li et al. BMC Cancer  (2015) 15:733 Page 4 of 14
Table 1 Characteristics of studies included in the meta-analysis



















M 10.1 35–54 21,735 46 FFQ Norwegian Cancer
Registry, death
certificates




F 10.1 35–54 21,238 32 FFQ Norwegian Cancer
Registry, death
certificates
≥7cups/d vs. ≤ 2cups/d 0.47 (0.16–1.39) No covariate adjustment 7
Bidel et al.,
2013, Finland




≥10cups/d vs. ≤ 0cup/d 0.53 (0.26–1.09) Age, study year, education,
cigarette smoking, alcohol
consumption, leisure time physical









≥10cups/d vs. ≤ 0cup/d 2.07 (0.53–8.15) Age, study year, education,
cigarette smoking, alcohol
consumption, leisure time physical









≥4cups/d vs. ≤ 1cup/d 1.86 (1.07–3.25) Age, time period, education,















≥7cups/d vs. ≤ 2cups/d 1.32 (0.76–2.30) Sex, age and residence 7
Nilsson et al.,
2010, Sweden
M/F 6 40–60 64,603 70 FFQ Regional cancer
registry, ICD-7codes
≥4cups/d vs. < 1cup/d 0.99 (0.44–2.21) Age, sex, BMI, smoking, education,








Took several times per
week + took every day
vs. took never + took
several times per year +
took several times
per month
1.00 (0.50–2.00) Age, smoking 9
Khan et al.,
2004, Japan




Took several times per
week + took every day
vs. took never + took
several times per year +
took several times
per month
0.30 (0.10–1.40) Age, health status, health
















M/F 9 40+ 26,311 419 FFQ Miyagi Prefectural
Cancer Registry
records
≥3cups/d vs. never 1.00 (0.60–1.60) Sex; age; type of health insurance;
history of peptic ulcer; cigarette
smoking; alcohol consumption;
daily consumption of rice; tea and
consumption of meat, green or
yellow vegetables, pickled










≥2cups/d vs. none 2.20 (0.90–5.30) Age, years of education, Japanese










≥2cups/d vs. none 1.60 (0.70–3.80) Age, years of education, Japanese





M 15 45–68 7,355 106 Interview Hawaii Tumor
Registry




















1.57 (1.03–2.39) Age, sex, tobacco smoking,
alcohol drinking, BMI, education,
ethnicity, usual physical activity
throughout the day, vigorous
physical activity, and the daily
intake of fruit, vegetables, red










1.06 (0.68–1.64) Age, sex, tobacco smoking,
alcohol drinking, BMI, education,
ethnicity, usual physical activity
throughout the day, vigorous
physical activity, and the daily
intake of fruit, vegetables, red













1.06(0.48–2.32) Age, interview year, dialect,
education, cigarette smoking
status, number of cigarettes
smoked per day, years smoked,














0.76(0.23–2.53) Age, interview year, dialect,
education, cigarette smoking status,
number of cigarettes smoked per
day, years smoked, BMI, caffeine,



















≥557 ml/d vs. never/<
131 ml/d
1.51(1.06–2.16) Age, center, smoking, BMI, physical
activity, education level, diabetes,
alcohol consumption, intake of
energy, fiber, vegetable, fruit, fish









≥557 ml/d vs. never/<
131 ml/d
0.72(0.47–1.08) Age, center, smoking, BMI, physical
activity, education level, diabetes,
alcohol consumption, intake of
energy, fiber, vegetable, fruit, fish
and red and processed meat
9










relation to coffee consumption. Eleven of 20 independ-
ent reports from 13 studies suggested a positive relation
between coffee consumption and gastric cancer, while
the other reports did not. Compared the lowest category
of coffee consumption, the pooled RR of gastric cancer
was 1.13 (95 % CI: 0.94–1.35) for the highest category of
coffee consumption. A moderate heterogeneity was
observed (P =0.044, I2 = 38 %).
Dose–response analysis of coffee consumption with the
risk of gastric cancer
Nine studies with 14 reports were included in the dose–re-
sponse analysis of coffee consumption and gastric cancer
risk. The pooled estimate for the risk ratio per 3 cups/day
increase in coffee was 1.03 (95 % CI, 0.95–1.11), with evi-
dence of moderate heterogeneity (I2 = 31.1 %, P = 0.127)
(Fig. 3). In the cubic spline model that included all studies,
we did not find evidence suggesting any nonlinear associ-
ation between coffee consumption and risk of gastric can-
cer (P for non-linearity = 0.68) (Fig. 4). Compared with
people who had no daily consumption of coffee, the RR of
gastric cancer estimated directly from the cubic spline
model was 0.98(95 % CI; 0.89–1.08) for 1 cups per day,
0.98 (95 % CI; 0.85–1.13 for 2 cups per day, 1.06 (9 5% CI;
0.91–1.25) for 6 cups per day, and 1.06(95 % CI; 0.90–1.25)
for 8 cups per day.
Subgroup analyses
Subgroup analyses were conducted to examine the sta-
bility of the primary results and explore the resource of
potential heterogeneity. No significant associations be-
tween coffee consumption and the risk of gastric cancer
was identified in most subgroup analyses, which were
stratified by sex, study quality, study location, follow-up
duration, reference group, dietary assessment method
(diet record/food frequency questionnaires versus other
methods), and whether age, smoking, BMI, alcohol in-
take, tea consumption were controlled or not in models.
However, a significant positive association between
coffee consumption and gastric cancer risk was
Fig. 2 Forest plot of coffee consumption and the risk of gastric cancer
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Fig. 3 Risk of gastric cancer associated with per 3cups/day in coffee consumption
Fig. 4 Dose–response relation plots between coffee consumption and the risk of gastric cancer
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observed in the United States (RR = 1.36, 95 % CI,
1.06–1.75, I2 = 0.00 %, P = 0.536) and in the groups of
equal to or less than 10 years follow-up (RR = 1.25, 95 %
CI, 1.01–1.55, I2 = 0.00 %, P = 0.493) (see Table 2).
Sensitivity analyses
Sensitivity analyses were used to find potential origins of
heterogeneity in the association between coffee consump-
tion and gastric cancer, and to examine the influence of
Table 2 Subgroup analyses of relative risk of gastric cancer
No of reports Relative risk (95 % CI) I2 P for heterogeneity
Sex
Men 8 1.17 0.88–1.55 37.10 % 0.133
Women 7 0.96 0.58–1.58 59.20 % 0.023
Combined 5 1.21 0.96–1.51 0.00 % 0.604
Study quality
Score > 7 13 1.10 0.85–1.43 47.10 % 0.030
Score≤ 7 7 1.20 0.94–1.53 20.10 % 0.276
Study location
United States 5 1.36 1.06–1.75 0.00 % 0.536
Europe 10 1.08 0.80–1.45 56.80 % 0.013
Asia 5 0.92 0.66–1.28 0.00 % 0.532
Follow-up duration
≤10 year 5 1.25 1.01–1.55 0.00 % 0.493
>10 year 15 1.06 0.82–1.37 47.10 % 0.022
Reference group
None 8 1.10 0.81–1.49 17.30 % 0.294
Low consumption 12 1.13 0.89–1.42 49.60 % 0.026
Specific dietary assessment method
Yes 11 1.10 0.87–1.38 41.50 % 0.072
No 9 1.17 0.85–1.61 40.30 % 0.099
Controlling age in models
Yes 17 1.15 0.95–1.39 36.90 % 0.064
No 3 0.88 0.42–1.85 61.90 % 0.073
Controlling smoking in models
Yes 13 1.06 0.84–1.33 43.80 % 0.046
No 7 1.29 0.97–1.71 21.80 % 0.263
Controlling BMI in models
Yes 9 1.06 0.81–1.40 46.80 % 0.058
No 11 1.19 0.92–1.53 33.70 % 0.129
Controlling alcohol intake in models
Yes 9 1.20 0.91–1.59 59.20 % 0.012
No 11 1.09 0.86–1.37 6.70 % 0.380
Controlling tea consumption in models
Yes 6 1.09 0.74–1.62 67.60 % 0.009
No 14 1.18 0.97–1.43 13.00 % 0.310
Statistical model*
Unadjusted 4 0.94 0.56–1.57 45.20 % 0.140
Adjusted 17 1.15 0.95–1.39 36.90 % 0.064
Abbreviations: BMI body mass index
*Study by Nilsson and colleagues reported results both statistical models for adjusted and unadjusted
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various exclusions on the combined RR, and check the ro-
bustness of all results above. Exclusion of two large sample
studies [36, 39], whose size was more than half of total
study samples showed a no statistically significant positive
association1.11 (95 % CI, 0.89–1.38), and a medium hetero-
geneity was observed (P = 0.128, I2= 29.6 %). We excluded
any single study in turn and pooled the results of remaining
studies, with a pooled RR of gastric cancer range from 1.09
(95 % CI, 0.90–1.32; P = 0.056)–1.19 (95 % CI, 0.99–1.41;
P = 0.125), which indicated that none of the individual
studies significantly influenced the overall result.
Publication bias
Visual inspection of a funnel plot did not identify substan-
tial asymmetry (see Fig. 5). The Begg rank correlation test
and the Egger linear regression test also indicated no
evidence of publication bias among the studies (Begg test
Z = 1.27, P = 0.206; Egger test t = −1.42, P = 0.173).
Discussion
This meta-analysis investigated the potential association
between coffee consumption and gastric cancer risk,
which based on 20 independent reports from 13 pro-
spective cohort studies, involving 1,372,811 participants
and 3,368 cases of new-onset gastric cancer. The results
showed no appreciable overall association between cof-
fee consumption and gastric cancer. Similar results were
obtained in most subgroup analyses. Evidence of a
nonlinear association of gastric cancer risk with coffee
consumption was not observed.
Comparison with previous studies
There were two meta-analyses published in 2014 [40]
and in 2015 [41] to investigate the evidence about coffee
consumption and gastric cancer. Results of this current
meta-analysis generally concur and further complement
the findings of previous review in several important as-
pects. In contrast to our results, Shen et al. found an
overall positive association of 1.24 (95 % CI: 1.03–1.49)
between the risk of gastric cancer and coffee consump-
tion. One possible reason was that the review by Shen
and colleagues only included eight studies involving
312,993 participants, and a few studies were missed,
which may overestimate the effect size. Additionally, the
review did not fully investigate other subgroups except
for gender, follow-up time and ethnicity and conduct the
dose–response analysis. Xie et al. indicated that no
significant association was observed between coffee con-
sumption and gastric cancer risk, which was consistent
with our result. Compared with the review, our meta-
analysis added one large scare cohort study with larger
sample size and many more cases, which significantly
enhanced statistical power to detect the potential associ-
ations of coffee consumption with gastric cancer. More
importantly, the nonlinear association between coffee
consumption and gastric cancer was investigated in
present meta-analysis.
In the subgroup analysis, we obtained two valuable
and important findings. A main finding was that the as-
sociation between coffee consumption and the risk of
gastric cancer was significant in the United States from
three studies comprising 500,825 participants, but not in
European and Japanese populations, which was a very
interesting phenomenon. According to the international
statistic of U.S Census Bureau [42], we could get the
total populations of countries included. Combining cof-
fee consumption data of them from International Coffee
Organization in 2010 [43], we could calculate the coffee
Fig. 5 Funnel plot of coffee consumption and the risk of gastric cancer
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consumption per capita. We found that coffee consump-
tion per capita (0.14 bags) among European countries
included in our meta-analysis were twice greater than in
the United States (0.07 bags), but did not observe an as-
sociation between the consumption of coffee and risk of
gastric cancer in European countries. In included ori-
ginal studies, we found that the average dose of coffee
consumption of highest categories in those European
populations is larger than in the United States. Con-
versely, it suggested that whether coffee consumption
might have protective effect on the incidence of gastric
cancer in some degree or not. The finding hints us that
it is needed to further explore the dose–response associ-
ation between coffee consumption and the risk of gastric
cancer in future studies. In linear dose–response ana-
lysis, we found that the pooled RR of gastric cancer risk
for an increase of coffee intake 2 cups per day was 0.98
(95 % CI, 0.85–1.13), which indicated that there were a
null inverse association between coffee and gastric can-
cer. The null association might result from the limited
included studies. We could preliminarily speculate that
the larger difference between the groups of the highest
and the lowest coffee consumption categories, the lower
the risk estimates, if coffee had a protective effect on
gastric cancer risk. Therefore, the lower risk estimates
could be explained in a few categories of coffee con-
sumption of our included studies. On the contrary, if
coffee had some effect on the risk of gastric cancer we
would expect the pooled RR to approach the null when
the references group of coffee consumption includes cof-
fee drinkers. According to available data, the pooled RR
compared the highest with the lowest groups (including
coffee drinkers) was 1.13 (95 % CI, 0.89–1.42), which
was from 8 studies with 12 reports involving 1,205,876
participants and 2,418 patients with gastric cancer. Of
course, this was likely to be an accidental finding. Add-
itionally, we suspected that there is a U-shaped association
between coffee consumption and gastric cancer risk in
some extent. However, in nonlinear dose–response ana-
lysis, we did not observe any nonlinear association be-
tween coffee consumption and gastric cancer risk to date,
which were likely limited by statistical power (nine studies
comprising 803,500 participants). It is unclear whether the
lack of a nonlinear dose–response association between
coffee consumption and the risk of gastric cancer was due
to potentially unfavorable effects of coffee at higher con-
sumption levels or was because of residual confounding
from other gastric cancer risk factors related to coffee
consumption. More studies are warranted to investigate
the potential difference between the different ethnic
backgrounds.
Interestingly, another important finding was that cof-
fee consumption increased the risk of gastric cancer in
the group of equal to or less than 10 years follow-up,
but did not have statistically significant association for
more than 10 years follow-up. One possible explanation
to this finding was that most studies have usually mea-
sured coffee consumption only once at the beginning of
the study, and have assessed the outcomes at the end of
the follow-up. Additionally, individuals frequently make
changes to their diet, thus, observational studies investi-
gating the association of baseline coffee consumption
with gastric cancer risk cannot adequately account for
mutative trends in intake. However, to our knowledge,
no study has examined the association between changes
in coffee and the risk of gastric cancer. We might pre-
liminarily speculate that the longer the follow-up dur-
ation, the more people could change their coffee intake,
which might weaken the association between coffee con-
sumption and gastric cancer risk. The interesting finding
deserves attention from related researchers. More stud-
ies investigating the association between changes in
coffee consumption and gastric cancer over time are
needed, which will help to explore the dose–response
relationship with them.
Coffee is a complex mixture of over a thousand chemi-
cals. Some constituents (such as very small amounts of
aromatic hydrocarbons and heterocyclic amines) have
been described as having genotoxic and mutagenic prop-
erties [11, 44]. For example, coffee contains acrylamide
and caffeine, which have potential carcinogenic effects
[45, 46]. In contrast, coffee contains many bioactive
compounds including phenolic acids with strong antioxi-
dant properties and cafestol and kahweol with anticarcino-
genic activity [47]. Our findings provided an importantly
open research thought for whether coffee consumption in-
deed had some degree protective effect on the incidence of
gastric cancer or not. However, it lacked comprehensively
biological mechanism research at the moment. Thus, both
population and animal studies are needed to strengthen
the exploration of biological mechanisms that link the
coffee consumption and gastric cancer.
It is well acknowledged that the coffee bean types
[48, 49], and roasting procedure [50] might affect cof-
fee chemical composition [51]. We could preliminarily
speculate that the difference conducting among geo-
graphic region might be that the type of coffee beans
(Robusta versus Arabica), brewing methods (Instant,
soluble, roast and ground), and caffeine content vary
among ethnic groups and cultures. However, most of
our included studies did not provide above detail in-
formation about coffee consumption characteristics.
Our study was unable to estimate the association be-
tween decaffeinated coffee and gastric cancer risk, because
only one study separately reported the risk estimates be-
tween them. However, the study analyzing decaffeinated
coffee consumption [39] found no relation with gastric
cancer risk. It is not possible to separate the drinkers of
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both caffeinated and decaffeinated coffee from drinkers of
decaffeinated coffee only. In general, drinkers consumed
low amount of decaffeinated coffee [51].
Strengths and limitations
Our review is very valuable and crucial though it is an
updated meta-analysis. Firstly, we not only included the
prospective cohort studies, also added 4 times as many
participants as the previous review, which provided
stronger and more reliable evidence. Secondly, on the
basis of our subgroup analysis, a significantly positive as-
sociation between coffee consumption and gastric cancer
risk was observed in the United States populations, which
provided a clue for future study of how the biological
mechanisms of coffee consumption and gastric cancer are
affected by ethnicity. Thirdly, we not only analyzed the as-
sociation of higher coffee consumption with gastric cancer
risk, but also conducted the dose–response analysis to
evaluate the linear and non-linear relations by using all
the categories of data, which could help to quantify
the associations and examine the shape of these possible
associations.
There are some limitations to this meta-analysis.
Firstly, different methods of assessment were used in the
included studies, and the units and cut-offs of coffee
consumption were heterogeneous across different stud-
ies. Nevertheless, we used RRs for the highest versus the
lowest category of coffee consumption, which could, to
some extent, reduce the bias caused by different units.
Secondly, the study relied on self-reported engagement
in coffee consumption, which was likely to cause the
misclassification of exposure, and may underestimate
the reported associations. Thirdly, our meta-analysis did
not take into consideration the differences of coffee bean
types, brewing methods, and serving sizes for coffee
among the included studies because of no sufficient
information in the original studies.
Some suggestions should be considered in future re-
search. Firstly, most of the studies included were con-
ducted in the United States and Europe, while only two
in Japan and one in Singapore. Given the underlying
disease-effect discrepancy among different geographic
locations and ethnicities, more studies should be con-
ducted in other populations from Asian, African and
South America. Secondly, in observational studies, inves-
tigators should pay attention to collect the information
on the types of coffee bean, brewing methods, roasting
procedure, preparation, cup size, and duration of use,
which might allow more detailed analysis into the asso-
ciation between the characteristic of coffee consumption
and gastric cancer risk. Thirdly, we should investigate
the association of changes in coffee consumption with
the occurrence of gastric cancer, and further accurately
assess the association between coffee consumption and
the risk of gastric cancer. Finally, coffee composition is
very complex, thus, more population-based epidemio-
logical investigations and animal experimental studies are
needed to further explore the potential biological mecha-
nisms link that the coffee intake and gastric cancer.
Conclusions
In conclusion, the results of this meta-analysis do not
support the hypothesis that higher coffee consumption
is associated with gastric cancer risk, and do not suggest
a nonlinear relationship between coffee consumption
and gastric cancer risk. Subgroup analyses suggest a
positive association between higher coffee consumption
and risk of gastric cancer in the United States population
and in the group of equal to or less than 10 years follow-
up. Studies with larger sample size and longer follow-up
time are warranted to confirm these subgroup results.
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